TC BioPharm (Holdings) plc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Randall Mark Edward, was filed 11 Jan 2023.
TC BioPharm (Holdings) plc: what insiders have been doing
TC BioPharm (Holdings) plc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at TC BioPharm (Holdings) plc has published a filing in the past twelve months. The most recent one dates from 11 January 2023.
Since 2022, the database holds 2 purchases and no sales by insiders of the company.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
- 70,000 shares@ US$5.00100.0% of flowOrdinary Shares [ADS]SEC:0001920179-23-000005:0Canonical exit: 28 Feb 2023 (T+90)
- ▲
Same trade as the filing by Mark Edward Randall, counted once
350,000 USD30SEC70,000 shares@ US$5.0093.8% of flowOrdinary Shares [ADS]SEC:0001920179-23-000004:0Canonical exit: 28 Feb 2023 (T+90) - ▲
Same trade as the filing by Mark Edward Randall, counted once
350,000 USD28SEC70,000 shares@ US$5.00100.0% of flowOrdinary Shares [ADS]SEC:0001920179-23-000001:0Canonical exit: 28 Feb 2023 (T+90) - ▲
Same trade as the filing by Mark Edward Randall, counted once
350,000 USD28SEC70,000 shares@ US$5.00100.0% of flowOrdinary Shares [ADS]SEC:0001920179-23-000006:0Canonical exit: 28 Feb 2023 (T+90) - 20,803 shares@ US$1.156.2% of flowOrdinary Shares [ADS]SEC:0001929926-22-000002:0Canonical exit: 22 Aug 2022 (T+90)
5 of 5 declarations
About TC BioPharm (Holdings) plc
TC BioPharm (Holdings) plc is a biopharmaceutical company focused on developing cell therapies for the treatment of cancer and other diseases. It is listed on NASDAQ.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
